Axogen, Inc. Cost of Revenue
Axogen, Inc. (AXGN) reported Cost of Revenue of $19.06 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-29
- Axogen, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $19.06M, a 30.14% increase year-over-year.
- Axogen, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $15.27M, a 12.04% increase year-over-year.
- Axogen, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $15.49M, a 30.98% increase year-over-year.
- Axogen, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $14.09M, a 15.43% increase year-over-year.
- Axogen, Inc. cost of goods and services sold for fiscal 2025 was $57.85M, a 27.54% increase from fiscal 2024.
- Axogen, Inc. cost of goods and services sold for fiscal 2024 was $45.36M, a 22.13% increase from fiscal 2023.
- Axogen, Inc. cost of goods and services sold for fiscal 2023 was $37.14M, a 24.75% increase from fiscal 2022.
- Axogen, Inc. cost of goods and services sold for fiscal 2022 was $29.77M, a 29.85% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 9 month as first filed | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.06M 10-Q · filed 2026-07-29 | $34.33M 10-Q · filed 2026-07-29 | $49.82M derived: sum of 3 quarters · filed 2026-07-29 | $63.91M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $15.27M 10-Q · filed 2026-04-28 | $30.76M derived: sum of 2 quarters · filed 2026-04-28 | $44.85M derived: sum of 3 quarters · filed 2026-04-28 | $59.50M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $15.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $29.58M derived: sum of 2 quarters · filed 2026-02-24 | $44.23M derived: sum of 3 quarters · filed 2026-07-29 | $57.85M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $14.09M 10-Q · filed 2025-10-29 | $28.73M derived: sum of 2 quarters · filed 2026-07-29 | $42.36M 10-Q · filed 2025-10-29 | $54.19M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $14.64M 10-Q · filed 2026-07-29 | $28.27M 10-Q · filed 2026-07-29 | $40.10M derived: sum of 3 quarters · filed 2026-07-29 | $52.31M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $13.63M 10-Q · filed 2026-04-28 | $25.46M derived: sum of 2 quarters · filed 2026-04-28 | $37.66M derived: sum of 3 quarters · filed 2026-04-28 | $50.23M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $11.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $24.04M derived: sum of 2 quarters · filed 2026-02-24 | $36.60M derived: sum of 3 quarters · filed 2026-02-24 | $45.36M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $12.21M 10-Q · filed 2025-10-29 | $24.77M derived: sum of 2 quarters · filed 2025-10-29 | $33.53M 10-Q · filed 2025-10-29 | $44.43M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $12.57M 10-Q · filed 2025-08-05 | $21.32M 10-Q · filed 2025-08-05 | $32.23M derived: sum of 3 quarters · filed 2026-02-24 | $41.79M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $8.76M 10-Q · filed 2025-05-08 | $19.66M derived: sum of 2 quarters · filed 2026-02-24 | $29.23M derived: sum of 3 quarters · filed 2026-02-24 | $37.73M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $20.47M derived: sum of 2 quarters · filed 2026-02-24 | $28.97M derived: sum of 3 quarters · filed 2026-02-24 | $37.14M 10-K · filed 2026-02-24 | $31.14M 10-K · filed 2024-03-05 | |||
| 2023-09-30 | $9.57M 10-Q · filed 2024-11-07 | $8.04M 10-Q · filed 2023-11-07 | $18.07M derived: sum of 2 quarters · filed 2024-11-07 | $26.24M 10-Q · filed 2024-11-07 | $21.98M 10-Q · filed 2023-11-07 | $38.01M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $8.50M 10-Q · filed 2024-08-08 | $7.23M 10-Q · filed 2023-08-08 | $16.68M 10-Q · filed 2024-08-08 | $13.94M 10-Q · filed 2023-08-08 | $28.44M derived: sum of 3 quarters · filed 2025-02-26 | $34.62M derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $8.17M 10-Q · filed 2024-05-02 | $6.71M 10-Q · filed 2023-05-09 | $19.94M derived: sum of 2 quarters · filed 2025-02-26 | $26.12M derived: sum of 3 quarters · filed 2025-02-26 | $32.40M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $11.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $17.95M derived: sum of 2 quarters · filed 2025-02-26 | $24.23M derived: sum of 3 quarters · filed 2025-02-26 | $29.77M 10-K · filed 2025-02-26 | $24.15M 10-K · filed 2023-03-14 | |||
| 2022-09-30 | $6.18M 10-Q · filed 2023-11-07 | $12.46M derived: sum of 2 quarters · filed 2023-11-07 | $18.01M 10-Q · filed 2023-11-07 | $23.43M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $6.28M 10-Q · filed 2023-08-08 | $11.83M 10-Q · filed 2023-08-08 | $17.26M derived: sum of 3 quarters · filed 2024-03-05 | $22.50M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | $5.55M 10-Q · filed 2023-05-09 | $10.97M derived: sum of 2 quarters · filed 2024-03-05 | $16.21M derived: sum of 3 quarters · filed 2024-03-05 | $23.30M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | $5.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $10.67M derived: sum of 2 quarters · filed 2024-03-05 | $17.76M derived: sum of 3 quarters · filed 2024-03-05 | $22.93M 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | $5.24M 10-Q · filed 2022-11-08 | $12.33M derived: sum of 2 quarters · filed 2022-11-08 | $17.50M 10-Q · filed 2022-11-08 | $22.97M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-06-30 | $7.09M 10-Q · filed 2022-08-05 | $12.26M 10-Q · filed 2022-08-05 | $17.73M derived: sum of 3 quarters · filed 2023-03-14 | $23.42M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-03-31 | $5.17M 10-Q · filed 2022-05-05 | $10.63M derived: sum of 2 quarters · filed 2023-03-14 | $16.33M derived: sum of 3 quarters · filed 2023-03-14 | $21.94M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2020-12-31 | $5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $11.16M derived: sum of 2 quarters · filed 2023-03-14 | $16.77M derived: sum of 3 quarters · filed 2023-03-14 | $21.58M 10-K · filed 2023-03-14 | ||||
| 2020-09-30 | $5.70M 10-Q · filed 2021-11-04 | $11.30M derived: sum of 2 quarters · filed 2021-11-04 | $16.12M 10-Q · filed 2021-11-04 | $21.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $5.61M 10-Q · filed 2021-08-05 | $10.42M 10-Q · filed 2021-08-05 | $15.30M derived: sum of 3 quarters · filed 2022-02-25 | $19.81M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $4.82M 10-Q · filed 2021-05-06 | $9.70M derived: sum of 2 quarters · filed 2022-02-25 | $14.21M derived: sum of 3 quarters · filed 2022-02-25 | $18.45M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $4.88M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $9.39M derived: sum of 2 quarters · filed 2022-02-25 | $13.63M derived: sum of 3 quarters · filed 2022-02-25 | $17.35M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $4.51M 10-Q · filed 2020-10-30 | $8.75M derived: sum of 2 quarters · filed 2020-10-30 | $12.47M 10-Q · filed 2020-10-30 | $16.11M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $4.24M 10-Q · filed 2020-08-07 | $7.96M 10-Q · filed 2020-08-07 | $11.60M derived: sum of 3 quarters · filed 2021-03-01 | $15.06M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $3.71M 10-Q · filed 2020-05-06 | $7.36M derived: sum of 2 quarters · filed 2021-03-01 | $10.82M derived: sum of 3 quarters · filed 2021-03-01 | $13.93M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $7.11M derived: sum of 2 quarters · filed 2021-03-01 | $10.21M derived: sum of 3 quarters · filed 2021-03-01 | $12.92M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $3.46M 10-Q · filed 2019-11-06 | $6.57M derived: sum of 2 quarters · filed 2019-11-06 | $9.28M 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | $3.11M 10-Q · filed 2019-08-06 | $5.82M 10-Q · filed 2019-08-06 | ||||||
| 2018-03-31 | $2.71M 10-Q · filed 2019-05-08 | |||||||
| 2017-12-31 | $9.31M 10-K · filed 2020-02-24 | |||||||
| 2016-12-31 | $6.47M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |